NCT00303485View on ClinicalTrials.gov

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Post Menopausal Osteoporosis
Interventions
DRUG

Placebo

po monthly for 6 months

DRUG

Vitamin D and calcium supplementation

As prescribed

DRUG

ibandronate [Bonviva/Boniva]

150mg po monthly for 6 months

Trial Locations (10)

10461

The Bronx

15445

Hopwood

30904

Augusta

53705

Madison

55125

Woodbury

90211

Beverly Hills

92093

La Jolla

00717-1318

Ponce

00927

San Juan

00935

San Juan

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00303485 - A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) | Biotech Hunter | Biotech Hunter